former CEO · Cardiff Oncology, Inc. (CRDF)

William Welch

A named executive officer of Cardiff Oncology in every fiscal year CompBrief holds from FY2017 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$769,564

Salary $630,152Stock awards $0

FY2017: $2,409,702

2nd of 3 named executive officers at Cardiff Oncology by FY2018 total.

3 named officers on file for Cardiff Oncology, FY2018

William Welch’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CRDF’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Cardiff Oncology’s whole pay program stands against its peers

  • Cardiff Oncology’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CRDF→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed January 1, 1900 (DEF 14A).

Free

Get William Welch’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

William Welch compensation by year

Cardiff Oncology Summary Compensation Table · all 2 fiscal years held
In US dollars, as Cardiff Oncology reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018
Salary$475,000$630,152
Bonus$0$0
Stock awards$1,123,314$0
Option awards$0$139,412
Non-equity incentive$811,388$0
Pension and deferred compensation$0$0
All other$0$0
Total$2,409,702$769,564

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cardiff Oncology, Inc. DEF 14A filed January 1, 1900, accession 0001104659-19-022622, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Cardiff Oncology, Inc. filed document, accession 0001104659-19-022622. Every figure is read from that document and cited to the page and table it appears in. Filed January 1, 1900.

$2.4M
$770K
FY17
FY18
SalaryNon-equity incentiveStock awardsOption awards

Cardiff Oncology’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
CSO Mark ErlanderCSO$908,524
William Welch · this pageformer CEO$769,564
Thomas AdamsCEO$377,192

The full Cardiff Oncology compensation record

free company brief

This page is one person within Cardiff Oncology's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cardiff Oncology's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Welch's compensation dossier · One-time report. No refunds.